Biosynthetic human growth hormone (hGH) specifically N-15 labelled in
the leucine residues has been obtained by recombinant DNA technology,
using N-15-labelled leucine and an E. coli strain that requires leucin
e. It is shown that, despite the possibility of minor transaminase act
ivity, the labelling on the whole is specific, and that the two-dimens
ional H-1-N-15 correlation NMR spectra of hGH can be greatly simplifie
d by this methodology.